Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Pitarangsi, C., Echeverria, P., Whitmire, R., Tirapat, C., Formal, S., Dammin, G. J., & Tingtalapong, M. (1982). Enteropathogenicity of Aeromonas hydrophila and Plesiomonas shigelloides: prevalence among individuals with and without diarrhea in Thailand. Infection and Immunity, 35(2), 666–673.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, and aquatic sources
DNA G+C(%): 51
|
NaCl >6%: 6(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: R(MIC50): 16, MIC90: -, RNG: (0.5->128)
aztreonam: S(MIC50): 0.03, MIC90: -, RNG: (0.015-128)
imipenem: S(MIC50): 1, MIC90: -, RNG: (0.25-1)
|
ceftazidime: S(MIC50): 0.125, MIC90: -, RNG: (0.03-4)
|
|
|
ciprofloxacin: S(MIC50): 0.03, MIC90: -, RNG: (≤0.03-2)
clinafloxacin: S(MIC50): 0.002, MIC90: -, RNG: (0.001-0.5)
levofloxacin: S(0.063)
nalidixic-acid: R(32)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: Var
|
|
|
sulfamethoxazole: R(5000)
trimethoprim: R(128)
SXT: Sens
co-trimoxazole: Var(MIC50): 4), MIC90: Var(4
|
|